Does the CLOCK Gene Decrease with Age and what does it have to do with Chronic Fatigue Syndrome and NRF2?


The CLOCK gene is one of the key components of the circadian rhythm, which regulates the biological processes in the body according to the day-night cycle. The circadian rhythm is closely linked to the cellular metabolism and the oxidative stress response, which are both important factors in chronic fatigue syndrome (CFS) and the activation of the Nrf2 pathway.

CFS is a complex disorder characterized by persistent and unexplained fatigue, pain, cognitive impairment and post-exertional malaise. The exact causes of CFS are not well understood, but some studies have suggested that it may be triggered by viral infections, immune dysfunctions, mitochondrial defects or environmental stressors. 

The Nrf2 pathway is a major defense mechanism against oxidative stress, which is caused by an imbalance between the production and elimination of reactive oxygen species (ROS). ROS are normal by-products of cellular metabolism, but they can also damage the DNA, proteins and lipids in the cells if not properly controlled. The Nrf2 pathway regulates the expression of several genes that encode for antioxidant enzymes, detoxification proteins and anti-inflammatory molecules.

The CLOCK gene may influence both CFS and the Nrf2 pathway through its role in regulating the circadian rhythm. The circadian rhythm affects the levels of different molecules in the cell, including ROS and Nrf2. Disruption of the circadian rhythm can lead to increased oxidative stress, inflammation and metabolic disturbances, which may contribute to the development or worsening of CFS symptoms. The CLOCK gene may decrease with age and may be one factor why CFS develops in many patients as they age.  Moreover, some studies have shown that the CLOCK gene itself can modulate the Nrf2 pathway by directly binding to its promoter region and enhancing its transcription.

However, the relationship between the CLOCK gene, CFS and the Nrf2 pathway is not straightforward and may depend on several factors, such as genetic variations, environmental exposures and disease stages. For example, some studies have reported that certain SNPs in the CLOCK gene are associated with increased risk or severity of CFS, while others have found no significant association. Similarly, some studies have suggested that Nrf2 activation may have beneficial effects for CFS patients by reducing oxidative stress and inflammation, while others have proposed that Nrf2 overactivation may be detrimental by inducing drug resistance and tumor development.

Therefore, more research is needed to elucidate the molecular mechanisms and clinical implications of the interactions between the CLOCK gene, CFS and the Nrf2 pathway. Understanding these interactions may help to identify novel biomarkers, diagnostic criteria and therapeutic targets for CFS patients.


References:

: https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03815-8

: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610158/

: https://www.frontiersin.org/articles/10.3389/fphys.2021.727806/full

: https://www.frontiersin.org/articles/10.3389/fphar.2021.719631/full

Comments